Evogene Ltd. EVGN
0.37 USD +0.08 (+29.39%)
At closeNov 10, 2026, 7:26 PM EST
0.33 -0.04 -11.72%
After hours · Nov 10, 7:26 PM ET
0.28 Day range 0.415
0.25 52-week range 1.28
- YTD
- -66.18%
- 1 year
- -68.74%
EVGN revenue history
Revenue is income from the company’s ordinary business activities.
3,503,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,503,000 | -2,074,000 | -37.19% |
| FY 2024 | 2024-12-31 | 5,577,000 | 2,595,000 | 87.02% |
| FY 2023 | 2023-12-31 | 2,982,000 | 1,307,000 | 78.03% |
| FY 2022 | 2022-12-31 | 1,675,000 | 745,000 | 80.11% |
| FY 2021 | 2021-12-31 | 930,000 | -110,000 | -10.58% |
| FY 2020 | 2020-12-31 | 1,040,000 | 287,000 | 38.11% |
| FY 2019 | 2019-12-31 | 753,000 | -994,000 | -56.90% |
| FY 2018 | 2018-12-31 | 1,747,000 | -1,634,000 | -48.33% |
| FY 2017 | 2017-12-31 | 3,381,000 | -3,159,000 | -48.30% |
| FY 2016 | 2016-12-31 | 6,540,000 | -4,589,000 | -41.23% |
| FY 2015 | 2015-12-31 | 11,129,000 | -3,382,000 | -23.31% |
| FY 2014 | 2014-12-31 | 14,511,000 | -3,070,000 | -17.46% |
| FY 2013 | 2013-12-31 | 17,581,000 | 509,000 | 2.98% |
| FY 2012 | 2012-12-31 | 17,072,000 | 2,171,000 | 14.57% |
| FY 2011 | 2011-12-31 | 14,901,000 | 2,338,000 | 18.61% |
| FY 2010 | 2010-12-31 | 12,563,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-29T06:00:50.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.